Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

44%

4 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 3

4(57.1%)

Phase 2

2(28.6%)

N/A

1(14.3%)

7Total

Phase 3(4)

Phase 2(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT03746665Phase 3Unknown

Maternal Immunization With MenAfriVac™

Role: collaborator

NCT02129829Completed

PROLIFICA - West African Treatment Cohort for Hepatitis B

Role: collaborator

NCT03353051Completed

Iron and Infection: Neonatal Nutritional Immunity

Role: collaborator

NCT01262872Phase 2Completed

Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants

Role: collaborator

NCT00561899Phase 2Completed

Comparison of Three Drug Combinations for Intermittent Treatment of Malaria in Children

Role: collaborator

NCT00120822Phase 3Completed

Folic Acid Supplementation in Gambian Primigravidae

Role: collaborator

NCT00120809Phase 3Completed

Intermittent Preventative Treatment With Sulfadoxine-Pyrimethamine in Gambian Multigravidae

Role: collaborator

NCT00131716Phase 3Completed

Prevention of Severe Anaemia in Gambian Children

Role: collaborator

NCT00558480Not ApplicableWithdrawn

Vitamin A Supplementation for Modulation of Mycobacterium Tuberculosis Immune Responses in Latent Tuberculosis

Role: collaborator

All 9 trials loaded